MX2011007462A - Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. - Google Patents
Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas.Info
- Publication number
- MX2011007462A MX2011007462A MX2011007462A MX2011007462A MX2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A
- Authority
- MX
- Mexico
- Prior art keywords
- scars
- wounds
- treatment
- post
- acid containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a composiciones farmacéuticas que mejoran el efecto terapéutico de péptidos biológicamente activos, en especial péptidos derivados de lactoferrina humana; las composiciones son útiles para el tratamiento y/o prevención de heridas, cicatrices y adhesiones postquirúrgicas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0900031 | 2009-01-13 | ||
PCT/EP2010/050284 WO2010081800A2 (en) | 2009-01-13 | 2010-01-12 | New pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2011007462A true MX2011007462A (es) | 2011-08-03 |
Family
ID=42340142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011007462A MX2011007462A (es) | 2009-01-13 | 2010-01-12 | Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. |
Country Status (15)
Country | Link |
---|---|
US (4) | US20110306565A1 (es) |
EP (1) | EP2387390B1 (es) |
JP (1) | JP5646507B2 (es) |
KR (1) | KR101406743B1 (es) |
CN (1) | CN102271658B (es) |
AU (1) | AU2010205751B2 (es) |
BR (1) | BRPI1006076B8 (es) |
CA (1) | CA2748860C (es) |
ES (1) | ES2400466T3 (es) |
HK (1) | HK1164701A1 (es) |
MX (1) | MX2011007462A (es) |
PL (1) | PL2387390T3 (es) |
RU (1) | RU2501566C2 (es) |
WO (1) | WO2010081800A2 (es) |
ZA (1) | ZA201105806B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2501566C2 (ru) | 2009-01-13 | 2013-12-20 | Пергамум АБ | Новые фармацевтические композиции |
CN103189078A (zh) * | 2010-10-29 | 2013-07-03 | 汇美迪斯有限公司 | 含有透明质酸和l-精氨酸的抗粘连剂 |
EP2481751A1 (en) | 2011-01-26 | 2012-08-01 | PharmaSurgics in Sweden AB | Human lactoferrin derived peptides |
WO2012154738A1 (en) | 2011-05-09 | 2012-11-15 | The Cleveland Clinic Foundation | Composition and method to improve intestinal health |
FR3002452B1 (fr) * | 2013-02-28 | 2016-02-12 | Dermaconcept Jmc | Composition dermatologique antimicrobienne topique |
CN111281978A (zh) * | 2019-08-19 | 2020-06-16 | 上海交通大学医学院附属第九人民医院 | 透明质酸基载体及其制备方法在抗瘢痕中的应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US5080893A (en) | 1988-05-31 | 1992-01-14 | University Of Florida | Method for preventing surgical adhesions using a dilute solution of polymer |
SE8900586L (sv) | 1989-02-21 | 1990-08-22 | Pharmacia Ab | Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader |
JP2818056B2 (ja) * | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | 抗菌性ペプチドおよび抗菌剤 |
IT1263394B (it) * | 1993-07-30 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati |
JPH0881387A (ja) * | 1994-09-09 | 1996-03-26 | Morinaga Milk Ind Co Ltd | 創傷治癒剤 |
US5690961A (en) | 1994-12-22 | 1997-11-25 | Hercules Incorporated | Acidic polysaccharides crosslinked with polycarboxylic acids and their uses |
DE69634823T2 (de) | 1995-08-29 | 2006-03-23 | Fidia Advanced Biopolymers S.R.L. | Aus hyaluronsäurederivaten bestehenden biomaterialien zur hemmung der postoperativen adhäsionsbildung |
US6037331A (en) | 1996-07-19 | 2000-03-14 | Poly-Med, Inc. | Compositions for prevention of inflammation and adhesion formation uses thereof |
US6515016B2 (en) * | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
JP2002519332A (ja) * | 1998-06-26 | 2002-07-02 | エヌ・ヴェー・ニュートリシア | 微生物によって引き起こされる表面感染症の治療または予防に使用するための医薬調製物 |
SE9804614A0 (en) * | 1998-07-06 | 2000-01-07 | A+ Science Invest Ab | New peptides and use thereof |
US7218503B2 (en) | 1998-09-30 | 2007-05-15 | Lam Research Corporation | Method of determining the correct average bias compensation voltage during a plasma process |
US6521223B1 (en) | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
CA2416126C (en) | 2000-07-28 | 2011-07-05 | Anika Therapeutics, Inc. | Bioabsorbable composites of derivatized hyaluronic acid |
KR100375299B1 (ko) | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
WO2002044276A2 (en) | 2000-11-28 | 2002-06-06 | Focal, Inc. | Polyalkylene glycol viscosity-enhancing polymeric formulations |
EP1284143A1 (en) | 2001-08-17 | 2003-02-19 | Sifi S.p.A | A process for the preparation of pharmaceutical formulations containing lactoferrin description |
SE0200667D0 (sv) * | 2002-03-05 | 2002-03-05 | A & Science Invest Ab | Novel use of cytokine inhibitors |
KR100523953B1 (ko) | 2002-08-27 | 2005-10-25 | 주식회사 엘지생명과학 | 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법 |
AU2004270815B2 (en) | 2003-09-11 | 2011-06-02 | Novozymes Adenium Biotech A/S | Recombinant production of antimicrobial agents |
KR101244519B1 (ko) | 2004-03-17 | 2013-03-18 | 젠자임 코포레이션 | 항점착 분무 |
ITPD20040245A1 (it) | 2004-10-08 | 2005-01-08 | Fidia Advanced Biopolymers Srl | Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali |
WO2006047744A2 (en) * | 2004-10-26 | 2006-05-04 | Agennix Incorporated | Compositions of lactoferrin related peptides and uses thereof |
EP1919500A2 (en) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
EP2050461A1 (en) * | 2007-10-19 | 2009-04-22 | PharmaSurgics in Sweden AB | Peptides based on the sequence of human lactoferrin and their use |
RU2501566C2 (ru) | 2009-01-13 | 2013-12-20 | Пергамум АБ | Новые фармацевтические композиции |
-
2010
- 2010-01-12 RU RU2011133224/15A patent/RU2501566C2/ru active
- 2010-01-12 WO PCT/EP2010/050284 patent/WO2010081800A2/en active Application Filing
- 2010-01-12 PL PL10700405T patent/PL2387390T3/pl unknown
- 2010-01-12 JP JP2011544890A patent/JP5646507B2/ja not_active Expired - Fee Related
- 2010-01-12 AU AU2010205751A patent/AU2010205751B2/en not_active Ceased
- 2010-01-12 KR KR1020117017898A patent/KR101406743B1/ko active IP Right Grant
- 2010-01-12 MX MX2011007462A patent/MX2011007462A/es active IP Right Grant
- 2010-01-12 US US13/143,875 patent/US20110306565A1/en not_active Abandoned
- 2010-01-12 CA CA2748860A patent/CA2748860C/en active Active
- 2010-01-12 CN CN2010800040649A patent/CN102271658B/zh active Active
- 2010-01-12 EP EP10700405A patent/EP2387390B1/en active Active
- 2010-01-12 BR BRPI1006076A patent/BRPI1006076B8/pt active IP Right Grant
- 2010-01-12 ES ES10700405T patent/ES2400466T3/es active Active
-
2011
- 2011-08-08 ZA ZA2011/05806A patent/ZA201105806B/en unknown
-
2012
- 2012-06-01 HK HK12105378.7A patent/HK1164701A1/xx not_active IP Right Cessation
-
2014
- 2014-08-13 US US14/458,637 patent/US9878019B2/en active Active
-
2017
- 2017-12-21 US US15/851,025 patent/US10471129B2/en active Active
-
2019
- 2019-08-29 US US16/555,708 patent/US11000574B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2010205751B2 (en) | 2013-05-02 |
US20200188490A1 (en) | 2020-06-18 |
US20110306565A1 (en) | 2011-12-15 |
BRPI1006076B1 (pt) | 2020-10-06 |
US20140349949A1 (en) | 2014-11-27 |
EP2387390A2 (en) | 2011-11-23 |
KR20110114610A (ko) | 2011-10-19 |
CA2748860C (en) | 2014-09-23 |
CA2748860A1 (en) | 2010-07-22 |
RU2011133224A (ru) | 2013-02-20 |
WO2010081800A2 (en) | 2010-07-22 |
KR101406743B1 (ko) | 2014-06-20 |
BRPI1006076A2 (pt) | 2016-04-19 |
EP2387390B1 (en) | 2012-11-28 |
ES2400466T3 (es) | 2013-04-10 |
JP5646507B2 (ja) | 2014-12-24 |
US10471129B2 (en) | 2019-11-12 |
US11000574B2 (en) | 2021-05-11 |
CN102271658B (zh) | 2013-06-12 |
US9878019B2 (en) | 2018-01-30 |
CN102271658A (zh) | 2011-12-07 |
PL2387390T3 (pl) | 2013-12-31 |
HK1164701A1 (en) | 2012-09-28 |
WO2010081800A3 (en) | 2010-11-25 |
US20180200341A1 (en) | 2018-07-19 |
BRPI1006076B8 (pt) | 2021-05-25 |
ZA201105806B (en) | 2012-04-25 |
RU2501566C2 (ru) | 2013-12-20 |
JP2012515151A (ja) | 2012-07-05 |
AU2010205751A1 (en) | 2011-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201490521A1 (ru) | Варианты фактора роста фибробластов 21 | |
WO2017044894A3 (en) | Cartilage-homing peptides | |
IN2012DN00971A (es) | ||
EA201492053A1 (ru) | Белки фактора роста фибробластов 21 | |
MY167691A (en) | A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid | |
EA201492064A1 (ru) | Варианты фактора роста фибробластов 21 | |
EP2444491A3 (en) | Hyperglycosylated human coagulation factor IX | |
MX2011007462A (es) | Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. | |
UA105036C2 (uk) | Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії | |
MY158325A (en) | Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection | |
MX350046B (es) | Tratamientos para trastornos gastrointestinales. | |
WO2010085039A2 (ko) | 노긴―유래 펩타이드 및 그의 용도 | |
GB2492935A (en) | Conjugated blood coagulation factor VIII | |
GB201001602D0 (en) | Oligopeptidic compounds and uses therof | |
MX2012013606A (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas. | |
MX2012006430A (es) | Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide. | |
WO2015157469A3 (en) | Polypeptide compositions with type vii collagen fibronectin type iii- like repeats and treatment methods for wound closure and healing | |
EA201270116A1 (ru) | Применение лекарственной формы для наружного нанесения, содержащей хитозан | |
MX2013007995A (es) | Peptidos derivados de lactoferrina humana y su uso. | |
EA201200428A1 (ru) | Композиция и способ для лечения ожирения | |
GEP201606514B (en) | Apoptosis inhibitors and usage thereof | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
MX2012013607A (es) | Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias. | |
MX336278B (es) | Composiciones y metodos para la prevencion y el tratamiento de heridas. | |
WO2014039074A3 (en) | Therapeutic compositions and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: PERGAMUM AB |
|
FG | Grant or registration |